Tag Archives: healthcare

Express Scripts Claims Shortfall Prompts Slight Miss in First Quarter and Guidance Reduction

Express Scripts Claims Shortfall Prompts Slight Miss in First Quarter and Guidance Reduction

Express Scripts reported underwhelming first-quarter results on Thursday evening. While the company continues to do an enviable job at driving improved profitability per claim, overall claims volume was light and management expects that pattern to persist for the full year, prompting a $0.06 per share EPS guidance reduction. Claims volume has been the company’s weakness

ZELTIQ Aesthetics First-Quarter Results: Strong Improvement

Friday afternoon, April 29, Zeltiq reported first-quarter revenues of $30.9 million (up 55%), $2.4 million above the Street’s estimate of $27.9 million. While both system and consumable sales were higher than our estimates, consumable sales drove the lion’s share of the beat. This is an encouraging signal—and one investors have been anxiously awaiting—as management’s investments

Healthcare Services Group Quarterly Results Exactly In Line With Expectations

On Tuesday after the markets closed, Healthcare Services Group (HCSG) reported in-line first-quarter 2014 results. More specific, the company reported total sales of $312.2 million, up 14.0% year-over-year and exactly in line with the consensus forecast; earnings per share were $0.21, also spot on the Street target. Top-line growth of 14.0% represented a solid acceleration

HealthStream ICD-10 Delay Should Be a Modest Positive

Last week, legislation delayed the transition to the ICD-10 coding system for one year, to October 1, 2015. HealthStream has captured meaningful market share for ICD-10 training, and revenue from ICD-10 content was 13% of sales in fourth quarter 2013, leaving some investors concerned that it is a temporary driver that has been inflating revenue

Cardinal Health, Inc. Expanding Preferred Products Platform With AccessClosure Acquisition

On Wednesday afternoon, April 2, Cardinal Health announced the acquisition of AccessClosure, a leading U.S. manufacturer of extravascular closure devices. Strategically, this deal provides Cardinal with a platform to expand its preferred products business into another physician preference category—cardiovascular